Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-13

Clinical Trial Update: Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating specialized pro-resolving lipid mediators for treatment-resistant depression is active but not recruiting, with inflammation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Specialized pro-resolving lipid mediators

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Treatment Resistant Depression, Inflammation | Phase 2 | Status: ACTIVE_NOT_RECRUITING